TruAlt Bioenergy Limited
TruAlt Bioenergy board will convene on May 22, 2026, to approve the audited standalone and consolidated financial results for the financial year ended March 31, 2026. This meeting will finalize the company's annual performance figures.
May 19 2026 18:05:00
TruAlt Bioenergy Limited
TruAlt Bioenergy's Board of Directors will convene on Friday, May 22, 2026. The agenda includes the consideration and approval of the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
May 19 2026 18:05:00
Trualt Bioenergy Ltd - 544545 - Board Meeting Intimation for Approval Of Audited (Standalone And Consolidated) Financial Results For The Quarter And Year Ended March 31, 2026.
Trualt Bioenergy's Board of Directors will meet on May 22, 2026. The primary agenda is to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
May 19 2026 18:05:00
Trualt Bioenergy Ltd - 544545 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Trualt Bioenergy has reported the utilization of its IPO proceeds for Q4 FY26. Out of Rs.750 crore gross proceeds, Rs.720.21 crore has been utilized for capital expenditure, working capital, and general corporate purposes, largely in line with plans. A minor delay in capital expenditure was noted due to vendor invoice receipts.
May 15 2026 12:05:00
TruAlt Bioenergy Limited
Trualt Bioenergy's bank loan facilities received 'IND A-/Stable/IND A2+' ratings from India Ratings & Research. These ratings cover ₹17,660 million in facilities, with a Stable outlook due to expected credit metric improvement from FY27.
Apr 28 2026 12:04:00
Read More